Publicacións en colaboración con investigadores/as de Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (9)

2024

  1. Assessment of Human SARS CoV-2-Specific T-Cell Responses Elicited In Vitro by New Computationally Designed mRNA Immunogens (COVARNA)

    Vaccines, Vol. 12, Núm. 1

  2. Author Correction: Modulating the immune response to SARS-CoV-2 by different nanocarriers delivering an mRNA expressing trimeric RBD of the spike protein: COVARNA Consortium (npj Vaccines, (2024), 9, 1, (53), 10.1038/s41541-024-00838-8)

    npj Vaccines

  3. Heterologous mRNA/MVA delivering trimeric-RBD as effective vaccination regimen against SARS-CoV-2: COVARNA Consortium

    Emerging Microbes and Infections, Vol. 13, Núm. 1

  4. Modulating the immune response to SARS-CoV-2 by different nanocarriers delivering an mRNA expressing trimeric RBD of the spike protein: COVARNA Consortium

    npj Vaccines, Vol. 9, Núm. 1

  5. Serological and Molecular Survey of Hepatitis E Virus in Small Ruminants from Central Portugal

    Food and Environmental Virology

2023

  1. Contemporary use of cefazolin for MSSA infective endocarditis: analysis of a national prospective cohort

    International Journal of Infectious Diseases, Vol. 137, pp. 134-143

2022

  1. In vitro neutralizing activity of BNT162b2 mRNA-induced antibodies against full B.1.351 SARS-CoV-2 variant

    Transboundary and Emerging Diseases, Vol. 69, Núm. 5, pp. 2649-2655

  2. Outpatient Parenteral Antibiotic Treatment vs Hospitalization for Infective Endocarditis: Validation of the OPAT-GAMES Criteria

    Open Forum Infectious Diseases, Vol. 9, Núm. 9

  3. Pitavastatin loaded nanoparticles: A suitable ophthalmic treatment for Acanthamoeba Keratitis inducing cell death and autophagy in Acanthamoeba polyphaga

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 180, pp. 11-22